Illumina, Inc. (NASDAQ:ILMN) announced that it will issue results for first quarter 2015 following the close of market on Tuesday, April 21, 2015.

On the same day, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern TimeJay Flatley, Chief Executive Officer, Francis deSouza, President, and Marc Stapley, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Tuesday, April 21, 2015. Interested parties may listen to the call by dialing 888.679.8034 (passcode: 50211546), or if outside North America by dialing +1.617.213.4847 (passcode: 50211546). Individuals may access the live teleconference in the Investor Relations section of Illumina’s web site under the “Company” tab at

A replay of the conference call will be available from 6:00 p.m. Pacific Time (9:00 p.m. Eastern Time) on April 21, 2015 through April 28, 2015 by dialing 888.286.8010 (passcode: 41280552), or if outside North America by dialing +1.617.801.6888 (passcode: 41280552). (Original Source)

Shares of Illumina closed yesterday at $182.79 . ILMN has a 1-year high of $213.33 and a 1-year low of $127.69. The stock's 50-day moving average is $193.05 and it's 200-day moving average is $185.96.

On the ratings front, Illumina has been the subject of a number of recent research reports. In a report issued on March 31, BTIG analyst Dane Leone maintained a Buy rating on ILMN, with a price target of $240, which represents a potential upside of 31.3% from where the stock is currently trading. Separately, on February 2, Cantor Fitzgerald's Sung Ji Nam maintained a Hold rating on the stock and has a price target of $166.

According to, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Dane Leone and Sung Ji Nam have a total average return of 11.1% and 13.5% respectively. Leone has a success rate of 69.6% and is ranked #990 out of 3568 analysts, while Nam has a success rate of 94.1% and is ranked #470.

In total, one research analyst has assigned a Hold rating and 5 research analysts have given a Buy rating to the stock. When considering if perhaps the stock is under or overvalued, the average price target is $182.79 which is 22.7% above where the stock closed yesterday.

Illumina Inc providessequencing-and array-based solutions for genetic analysis. Its products enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease, and drug response.